This is precisely the question. There is no open research on PFCEs or HBOCs as PED. No ethics committee would ever allow that. Maybe there's military research? Maybe a few rogue scientists? I do not know.
What I know, I know from open sources, and they're silent about PFCEs and HBOCs as PEDs. So, it goes without saying that all of this is speculation.
Now, fact is that the limitation for power output is oxygen availability. That's why there's aerobe and anaerobe power output, the latter being higher. That's also why additional Hb (by whatever means, increased production via EPO/CERA or transfusions homologue/autologue) will increase power output so dramatically.
With this as a starting point, it sounds logical that PFCEs and HBOCs would increase power output as well possibly up to the anaerobe threshold (but sustained!!), but as I said, we're not on firm ground here any more. Both PFCEs and HBOCs are smaller than RBC, they dissolve in the plasma, meaning they can enter the smallest capillaries more easily. Ironically, this effect is used experimentally in
cancer treatment . It helps inner tumor cells (which are typically O2 starved) to get up to a normal O2 level, so they start to divide more frequently at which point e.g. radiation therapy can take them out.
So, due to their flow properties (their small size really) PFCEs and HBOCs would be more ideal O2 carriers than RBCs. However, they wont last more than, say, a day (and I think Dr. House was ignorant on this point in his rants about cowblood) which is a problem in terms of effect and for the body to get rid of metabolites (the latter will take a week, within which one really shouldn't take another dose).
Now, when you look at very recent performances in GTs (say since the CERA test), what struck me is that most good riders have 1-2 really good days, but not typically a freakish third week as in, say, the early 2000s. Consistent with PFCEs/HBOCs. Also, some riders might take greater risks and take more than 1 dose per week (maybe 2 or 3) and in order to manage possible side effects (e.g. possible liver toxicity, kidney problems, effects on the central nervous system) they have to take some heavy hitting other medication which you brought up in your first post. Now, maybe I've arrived in fantasy land here. There's little known in the literature of side effects of overuse of PFCEs and HBOCs in trauma patients. And even then, things might be different for healthy endurance athletes. So who knows.
Anyway, I'm interested in your speculation. I'm not sure I understood what you were hinting at. An experimental drug to increase O2 carrying efficiency of Hb? That would of course boost the effect of transfusions as well. Could you point me to a write-up on it, aimed at the interested layman?